Adalimumab is a monoclonal antibody used as a biologic medication to treat autoimmune diseases by targeting tumor necrosis factor alpha. It is administered by injection and is typically prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The name itself reflects its therapeutic class and molecular design rather than a clinical description.
Full pronunciation guide
